MedPath

Effectiveness of whey peptide and ripening extract of hop for Japanese patients of mild Alzheimer's disease

Not Applicable
Conditions
Alzheirmer's disease
Registration Number
JPRN-jRCTs031180222
Lead Sponsor
Katsuta Narimasa
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Meeting the clinical criteria for Alzheimer's disease according to NINCDS-ADRDA, and features of brain MRI examination and brain blood flow of Single photon emission computed tomography (SPECT), and 17~23 of MMSE score

Exclusion Criteria

Meeting the following criteria
1) Sever cognitive impairment and no comprehensive
2) Allergy for the milk protein
3) Chronic inflammatory disease including kidney failure and collagenosis
4) Obesity in medium degree (BMI over 30)
5) Smoker or heavy alcohol drinker

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ADAS-Jcog, MMSE
Secondary Outcome Measures
NameTimeMethod
SPECT, Inflammatory marker, POMS2
© Copyright 2025. All Rights Reserved by MedPath